- A Prospective, Multicenter, Open-label Trial of Zoledronic Acid in Patients with Hormone Refractory Prostate Cancer
-
Hong SJ, Cho KS, Cho HY, Ahn H, Kim CS, Chung BH
- KMID: 1786216
- Yonsei Med J.
- 2007 Dec;48(6):1001-1008.
- doi: 10.3349/ymj.2007.48.6.1001
PURPOSE: The short-term safety and efficacy of zoledronic acid for the treatment of skeletal metastasis was evaluated in patients with hormone-refractory prostate cancer. PATIENTS AND METHODS: A total of... -
- CITED
-
- Close
- SHARE
-
- Close
